By Phrmicell Lab Luxury Cell Performance BB Cream_50g
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- Category
- Face Cream & Lotion
Pharmicell Co., Ltd.
- Verified Certificate
-
12
Product name | By Phrmicell Lab Luxury Cell Performance BB Cream_50g | Certification | - |
---|---|---|---|
Category | Face Cream & Lotion | Ingredients | - |
Keyword | - | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | Stock | - | |
Supply type | - | HS code | - |
Product Information
Beautiful zero-defect skin that shines By Pharmicell Lab Prestige BB Cream 50g (UVA PA++ / UVB(SPE30))
As a certified triple function cosmetic ( wrinkle alleviation, whitening and blocking ultraviolet ray) that contains human bone marrow stemcell conditioned media, it can help you help you cultivaten clean and moist skin.
Product introduction
By Phrmicell Lab Luxury Cell Performance BB Cream_50g |
Containing 3% of human bone marrow stem cell conditioned media/Certified as wrinkle-improving cosmetic.
Triple gunction BB Cream for wrinkle alleviation, whitening and blocking ultravuiet ray, that uses inorganic powder (C.P) for clear skin tone and skin correnction, containing functional test ingredients
- All Types of resourceful substances of human hone marrow stem cell conditioned media, Jewely complex, Guava and palboseunggidan substances contained this product not only supply sufficient amount of untrition and moisture to your skin, but also helps soothe your skin. Moreover, it givesyou a naural skin tone by controlling sebum and covering blemishes. You can maintain soft and silky skin all day long with a light touch of the BB cream.
Main Ingredients
- Human bone marrow stem cell conditioned media 3%, adenosine, pearl powder, rehmanniaglutinosa liboschitz var. purpurea Makino extract, peony extract, cnidium extract.
6Free
- No parabenes, no mineral oil, no GMO, No artificial fregrance, no formaldehyde and no 1.4 dioxin
How to use
- Apply appropriate portion of the product at the last stage of basic skin care, and spread evenly on your skin
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Hyeonsoo Kim
- Address
- 12F, Chungho-B/D, 3-2, Nonhyeon-dong, Gangnam-gu, Seoul, Korea
- Product Category
- Makeup Brushes
- No. of Total Employees
- 101-500
- Company introduction
-
Pharmicell is devoting itself to the development and commercialization if stem cell therapeutics for the conquest of incurable diseases such as cancer, brain and nervous system disorders, heart diseases that are the most fatal to human beings. Pharmicell is planning to accelerate the development of stem cell therapeutics for acute ischemic stroke(IND-phase 3)and chronic spinal cord injury(IND-phase 2/3)with the experiences relating to the NDA approval of stem cell therapeutics for acute myocardial infarction. In addition, we will continuously launch stem cell therapeutics according to our new drug development pipeline to treat alcoholic cirrhosis, pulmonary fibrosis, and cancer under investigator?s trials and thereby give hope to the patients who are suffering from these incurable diseases. Moreover, we will contribute to the vitalization of the industry related to stem cells through commercialization of stem cell therapeutics, stem cell banking, cell media, CMO(contract Manufacturing Organization), stem cell culturing media, cell processing equipment, cell transport box, manufacturing and quality control software by utilizing our know-how accumulated in the process of commercialization of stem cell therapeutics. This company has secured the intellectual property rights through the registration of patent for stem cell differentiation technology(dendritic cell production technology for anticancer immune treatment and production technology of nerve cells for treatment of brain and nervous system disorders) in foreign countries(7 countries including the US and EU) in order to gain technological competitive edge in the global markets.
- Main Product